Head-to-head · WeighScore
Tryozi vs Vida Health
The verdict
Tryozi takes it — 61.4/100 to 55.2/100.
Tryozi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Florida telehealth selling compounded GLP-1 injections at a flat price that does not rise with dose, naming all four of its 503A compounding pharmacies.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Tryozi | Vida Health |
|---|---|---|
| WeighScore | 61.4/100 | 55.2/100 |
| Grade | C | C |
| Scorecard rank | #294 | #446 |
| Semaglutide | $279/mo (compounded) | Not disclosed |
| Tirzepatide | $379/mo (compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #294 · C
Strengths
- Names all four of its 503A compounding pharmacies: RedRock, Health Warehouse, Precision Medicine and Triad Rx
- Price does not increase as your dose increases, stated plainly on the pricing page
- Full total shown before payment, with the first-month discount and the ongoing rate both visible
- States plainly that compounded medications are not FDA-approved, a disclosure many competitors omit
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Headline $139 is a first-month half-price offer; the ongoing rate is $279
- Multi-week plans are billed once as a single upfront charge, not as a lower monthly rate
- Plans ship every 4 weeks, so a 52-week plan is 13 shipments rather than 12 months
- No refund policy detail is published on the pricing page itself
Graded #446 · C
Strengths
- Medical Weight Loss program includes anti-obesity GLP-1 medications
- Pairs medication with behavioral-health coaching and medical management
- Whole-person care across chronic conditions, sleep, and nutrition
- Integrates with major health plans, PBMs, and benefit platforms
- Established virtual chronic-care platform
Where it loses points
- Distributed mainly via employers and health plans, not direct cash-pay
- Access usually requires employer or plan sponsorship
- No public consumer GLP-1 pricing
- Clinician credentials not detailed publicly
- Less suited to consumers wanting direct-to-door GLP-1
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.